| 10561654 |
Pharmaceutical formulations of (S)-methyl(1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate |
Daya Verma, Yogita Krishnamachari, Hanchen Lee, Ping Li, Rajinder Singh +1 more |
2020-02-18 |
| 10517832 |
Tamper resistant pharmaceutical formulations |
Rama Abu Shmeis, Sheetal R. Muley, Zhixin Zong |
2019-12-31 |
| 10258622 |
Method of treating colorectal cancer by administration of pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)pheny1)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl) carbamate |
Daya Verma, Yogita Krishnamachari, Hanchen Lee, Ping Li, Rajinder Singh +1 more |
2019-04-16 |
| 10195152 |
Tamper resistant pharmaceutical formulations |
Rama Abu Shmeis, Sheetal R. Muley, Zhixin Zong |
2019-02-05 |
| 9763941 |
Method of treating melanoma by administration of pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate |
Daya Verma, Yogita Krishnamachari, Hanchen Lee, Ping Li, Rajinder Singh +1 more |
2017-09-19 |
| 9616030 |
Tamper resistant pharmaceutical formulations |
Rama Abu Shmeis, Sheetal R. Muley, Zhixin Zong |
2017-04-11 |
| 9387208 |
Pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate |
Daya Verma, Yogita Krishnamachan, Hanchen Lee, Ping Li, Rajinder Singh +1 more |
2016-07-12 |